Literature DB >> 6295489

Characterization of cyclic 3':5'-amp-dependent protein kinase in sarcoplasmic reticulum and cytosol of canine myocardium.

E G Kranias, A Schwartz, R A Jungmann.   

Abstract

Canine cardiac sarcoplasmic reticulum vesicles contain intrinsic cAMP-dependent and Ca2+ -calmodulin-dependent protein kinase (EC 2.7.1.37) activities and a common substrate, phospholamban, for these enzymes. Cyclic AMP-dependent protein kinase associated with sarcoplasmic reticulum membranes was solubilized with Triton X-100. Solubilization of the sarcoplasmic reticulum protein kinase did not affect its dependency on cAMP or its substrate specificity. The solubilized cAMP-dependent protein kinase was purified by DEAE-cellulose chromatography and was characterized as a type II enzyme on the basis of its elution at high ionic strength. DEAE-purified cAMP-dependent protein kinase exhibited no Ca2+ -calmodulin-dependent protein kinase activity. Cytosol from canine cardiac muscle cells, chromatographed on DEAE-cellulose under conditions identical to those used with sarcoplasmic reticulum, exhibited the presence of both type I and type II cAMP-dependent protein kinase isozymes. The properties of the DEAE-cellulose purified type II protein kinases from sarcoplasmic reticulum and cytosol were similar. We conclude that cardiac sarcoplasmic reticulum contains primarily type II cAMP-dependent protein kinase and this is probably the enzyme which phosphorylates sarcoplasmic reticulum in vivo and regulates Ca2+ transport.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6295489     DOI: 10.1016/0167-4838(82)90417-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Comparison of calcium release from sarcoplasmic reticulum of slow and fast twitch muscles.

Authors:  Y S Lee; K Ondrias; A J Duhl; B E Ehrlich; D H Kim
Journal:  J Membr Biol       Date:  1991-06       Impact factor: 1.843

2.  The role of phospholamban in the regulation of calcium transport by cardiac sarcoplasmic reticulum.

Authors:  B A Davis; I Edes; R C Gupta; E F Young; H W Kim; N A Steenaart; G Szymanska; E G Kranias
Journal:  Mol Cell Biochem       Date:  1990-12-20       Impact factor: 3.396

3.  Regulation of rat cardiac nuclei-associated Mg(2+)-NTPase by phosphorylation.

Authors:  R C Gupta; E F Young; D G Ferguson; E G Kranias
Journal:  Mol Cell Biochem       Date:  1991-04-10       Impact factor: 3.396

4.  Characterization of the molecular form of cardiac phospholamban.

Authors:  J M Harrer; E G Kranias
Journal:  Mol Cell Biochem       Date:  1994-11-23       Impact factor: 3.396

5.  Phosphorylation and functional modifications of sarcoplasmic reticulum and myofibrils in isolated rabbit hearts stimulated with isoprenaline.

Authors:  E G Kranias; J L Garvey; R D Srivastava; R J Solaro
Journal:  Biochem J       Date:  1985-02-15       Impact factor: 3.857

6.  Increased inhibition of SERCA2 by phospholamban in the type I diabetic heart.

Authors:  Zainisha Vasanji; Naranjan S Dhalla; Thomas Netticadan
Journal:  Mol Cell Biochem       Date:  2004-06       Impact factor: 3.396

7.  Selective inhibitors of cardiac ADPR cyclase as novel anti-arrhythmic compounds.

Authors:  Aimo Kannt; Kerstin Sicka; Katja Kroll; Dieter Kadereit; Heinz Gögelein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-04-19       Impact factor: 3.000

8.  Localization of phospholamban in smooth muscle using immunogold electron microscopy.

Authors:  D G Ferguson; E F Young; L Raeymaekers; E G Kranias
Journal:  J Cell Biol       Date:  1988-08       Impact factor: 10.539

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.